Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome / 中国药房
China Pharmacy
; (12)2001.
Article
em Zh
| WPRIM
| ID: wpr-533603
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE:To observe the clinical effect of Shenmai injection for primary sjogren syndrome.METHODS:61 patients were randomized to receive anethole trithione (control group,n=29) or anethole trithione and Shenmai injection (treatment group,n=32) respectively with 15 days as a course of treatment.RESULTS:The total effective rate was 68.96% for control group and 90.63% for treatment group.There were 3 cases of abdominal discomfort ordiarrhea in control group,and no serious ADR was detected in treatment group.Significant difference was noted between two groups (P
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Clinical_trials
Idioma:
Zh
Revista:
China Pharmacy
Ano de publicação:
2001
Tipo de documento:
Article